Conference Reports for NATAP
HIV Glasgow 2026
8-11 November
Back
 
Tweet
Hepatitis B after switch to long-acting cabotegravir/rilpivirine: data from the SCohoLART study
Glasgow 2026 Nov 8-11
Angelo Roberto Raccagni